Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
Caroline Dorsa to retire from the Biogen Board of Directors; Dr. Maria C. Freire, Director since 2021, elected as new…
Silvia Corvera, MD, and Michael Czech, PhD, Join SAB to Advance Autologous Regenerative Cell PlatformLEAWOOD, Kan., Feb. 11, 2026 (GLOBE…
SAN CARLOS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,…
– Webcast to be held Wednesday, February 11, 2026, at 8:00 a.m. ET –WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE)…
Châtillon, France, February 9, 2025 DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies (Euronext:…
ALISO VIEJO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) — SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company,…
ANTWERP, Belgium, February 9, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on…
BOSTON, Feb. 09, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system…
TOKYO and CAMBRIDGE, Mass., Feb. 08, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and…